![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name
(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl trihydrogen diphosphate | |
Identifiers | |
| |
3D model (JSmol) |
|
ChemSpider |
|
MeSH | farnesyl+pyrophosphate |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C15H28O7P2 | |
Molar mass | 382.330 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Farnesyl pyrophosphate (FPP), also known as farnesyl diphosphate (FDP), is an intermediate in the biosynthesis of terpenes and terpenoids such as sterols and carotenoids.[1] It is also used in the synthesis of CoQ (part of the electron transport chain), as well as dehydrodolichol diphosphate (a precursor of dolichol, which transports proteins to the ER lumen for N-glycosylation).
Farnesyl pyrophosphate synthase (aprenyl transferase)[2] catalyzes sequential condensation reactions of dimethylallyl pyrophosphate with 2 units of 3-isopentenyl pyrophosphate to form farnesyl pyrophosphate, as is shown in the following two steps:
The above reactions are inhibited by bisphosphonates (used for osteoporosis).[3] Farnesyl pyrophosphate is a selective agonistofTRPV3.[4]
| |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mevalonate pathway |
| ||||||||||
Non-mevalonate pathway |
| ||||||||||
ToCholesterol |
| ||||||||||
From Cholesterol toSteroid hormones |
| ||||||||||
Nonhuman |
|